Cme Group Inc. (CME) Stock Price & Analysis
Cme Group Inc. (CME) rose 0.39% to USD 255.31 as of July 25, 2026 at 01:12 UTC, according to Nexqual real-time market data.
CME last closed at USD 254.32; the session ranged USD 251.35–256.16 on volume of 1,708,539 shares. Market capitalization is $92.25B, with a 52-week range of USD 218.31–329.16 (NMS). Source: Nexqual, July 25, 2026 at 01:12 UTC.
Key Statistics (as of July 25, 2026 at 01:12 UTC)
| Price | USD 255.31 |
|---|---|
| Change | ▲ 0.39% (up) |
| Previous Close | USD 254.32 |
| Open | USD 254.2 |
| Day Range | USD 251.35 – 256.16 |
| 52-Week Range | USD 218.31 – 329.16 |
| Volume | 1,708,539 shares |
| Market Cap | $92.25B |
| Exchange | NMS |
Technical Analysis (CME)
Nexqual's technical model rates CME "NEUTRAL" based on 3 bullish and 3 bearish signals across 125 daily candles, as of July 25, 2026 at 01:12 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 58.31 (neutral) |
| vs SMA50 | Below (USD 256.52) |
| MACD | -0.39 (negative) |
Analyst Ratings (CME)
Wall Street analysts rate CME "Buy" based on 15 analysts, with a mean price target of USD 283.93 (range USD 230–330), per Nexqual as of July 25, 2026 at 01:12 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 15 |
| Mean Target | USD 283.93 |
| High Target | USD 330 |
| Low Target | USD 230 |
| Buy / Hold / Sell | 9 / 4 / 3 |
Earnings (CME)
| Next Earnings Date | 2026-10-21 |
|---|---|
| EPS Estimate | USD 2.94 |
| Revenue Estimate | $1.70B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 2.99 vs est 2.91 ▲ beat |
| 2026-03-31 | USD 3.36 vs est 3.37 ▼ miss |
| 2025-12-31 | USD 2.77 vs est 2.74 ▲ beat |
| 2025-09-30 | USD 2.68 vs est 2.63 ▲ beat |
Source: Nexqual, July 25, 2026 at 01:12 UTC.
Financials & Fundamentals (CME)
| Total Revenue | $6.76B |
|---|---|
| Revenue Growth (YoY) | +1.00% |
| Gross Margin | +100.00% |
| Operating Margin | +64.89% |
| Profit Margin | +63.43% |
| ROE | +15.80% |
| Debt / Equity | 12.91 |
| Current Ratio | 1.02 |
| Total Cash | $2.48B |
| Total Debt | $3.42B |
Source: Nexqual, July 25, 2026 at 01:12 UTC.
Financial Health Score (CME)
Nexqual rates Cme Group Inc.'s overall financial health "Solid" across five dimensions, as of July 25, 2026 at 01:12 UTC.
| Growth | Solid — Revenue +6% YoY (annual) |
|---|---|
| Profitability | Strong — Operating margin 65% |
| Balance Sheet | Strong — $2.48B cash vs $3.42B debt |
| Cash Flow | Mixed — No data |
| Efficiency | Solid — ROE 16%, ROA 1.5% |
Ownership (CME)
| Insider Ownership | +0.42% |
|---|---|
| Institutional Ownership | +92.37% |
| Shares Outstanding | 361.32M |
| Float | 355.65M |
| Short % of Float | +1.85% |
Source: Nexqual, July 25, 2026 at 01:12 UTC.
Leadership (CME)
Cme Group Inc. is led by Terrence A. Duffy (age 67), Chairman & CEO, per Nexqual as of July 25, 2026 at 01:12 UTC.
| Chairman & CEO | Terrence A. Duffy (age 67) |
|---|---|
| Senior MD, President & CFO | Lynne C. Fitzpatrick (age 47) |
| Senior MD, Group COO & Global Head of Clearing | Suzanne Sprague |
| Senior Managing Director of Corporate Marketing & Communications | Anita Liskey (age 60) |
Major Backers & Investors (CME)
Notable institutional backers of Cme Group Inc. include JPMorgan, Morgan Stanley, Capital Group, according to Nexqual as of July 25, 2026 at 01:12 UTC.
Active Investors
| Investor | Stake |
|---|---|
| JPMorgan | 3.37% |
| Morgan Stanley | 2.6% |
| Capital Group | 1.91% |
| Price (T.Rowe) Associates Inc | 1.33% |
| Fidelity | 1.27% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 15.53% |
| BlackRock | 9.99% |
| State Street | 5.64% |
| Geode Capital | 2.52% |
| BNY Mellon | 1.33% |
Source: Nexqual, July 25, 2026 at 01:12 UTC.
From Cme Group Inc.'s Latest SEC 10-K Filing (filed 2026-02-26)
Key Strengths & Strategy (as disclosed to the SEC)
- This includes, but is not limited to, the successful development and migration of our markets and supporting operational and business functions to the Google Cloud in the new private Google Cloud region.
- We attempt to protect our proprietary technology and intellectual property rights by relying on patents, trademarks, copyright, database rights, trade secrets, restrictions on disclosure, and other methods.
- Notwithstanding the precautions we take to protect our proprietary technology and intellectual property rights, it is possible that employees or third parties may copy, misappropriate, or otherwise obtain and use our proprietary technology without authorization or otherwise infringe on our rights.
- Our business is dependent on proprietary technology and intellectual property that we own or license from third parties.
Partnerships
- We may issue additional equity and/or debt as part of strategic partnerships with third parties, as was the case in connection with our partnership with Google Cloud.
- Our usage of mobile, web, and cloud technologies, such as those pursuant to our partnership with Google Cloud, may increase our risk of a cyber attack.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ICE | Intercontinental Exchange Inc. | USD 145.79 | ▲ 2.29% |
| CBOE | Cboe Global Markets, Inc. | USD 285.07 | ▲ 1.16% |
| NDAQ | Nasdaq, Inc. | USD 92.09 | ▲ 1.31% |
| SPGI | S&P Global Inc. | USD 426.4 | ▼ 0.62% |
| MCO | Moody's Corporation | USD 471.5 | ▼ 3.72% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:12 UTC. This page is informational and not investment advice.